PRINCETON, N.J., May 7 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bullentin Board: DSCI), provider of advanced wound care products, announced plans to release its first quarter 2008 results before market on Thursday, May 15, 2008. The Company will hold a conference call that same day to discuss the results at 11:00 am EDT. Interested parties should call 866 202 4683 (domestic) or 617 213 8846 (international), with passcode 26916332 to access the call. You may also access this call via the Internet at:
http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=1830398
For those who are unavailable to listen to the live broadcast, a replay will be available through June 15, 2008 and can be accessed by dialing 888 286 8010 (domestic) and 617 801 6888 (international) and using passcode is 80070508.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced wound-
care products. Its key product, MEDIHONEY, is sold throughout the world by
Derma Sciences and Comvita New Zealand - the licensor of the patented
honey- based technology - and is the leading brand of honey-based dressings
for the management of wounds and burns. The product has been shown to be
effective in variety of wounds and burns, and was recently the focus of a
large scale randomized controlled trial on leg ulcers. For more information
about Derma Sciences, Inc., visit its home page on the Internet at
http://www.dermasciences.com .
Contact: Derma Sciences, Inc. Allen & Caron Inc
Edward J. Quilty Rudy Barrio (US Investors)
Chairman and CEO r.barrio@allencaron.com
| SOURCE Derma Sciences, Inc. Copyright©2008 PR Newswire. All rights reserved |